New Biotech ETF Steers Away From the Traditional
January 02, 2015 at 13:35 PM EST
Investors love health care exchange traded funds and they like the more traditional offerings. That much is confirmed by the roughly $2.5 billion combined that flowed into the Health Care Select Sector SPDR (NYSEArca: XLV) and the Vanguard Health Care ETF (NYSEArca: VHT) last year. However, ETF...